Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Racial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-center study

2 Jan 2015

Abstract excerpt

We examined four clinically assessed cytogenetic subtypes (t(11;14), t(4;14), monosomy 13/del13q and monosomy 17/del17p in 292 black patients with newly diagnosed multiple myeloma (MM) from four medical centers, who had fluorescent in situ hybridization testing results available in their medical records. We then compared the prevalence of these abnormalities with a previously characterized Mayo Clinic cohort of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chronic Lymphocytic Leukemia Research
Share to Monoclonal and Polyclonal Antibodies Research
Share to Multiple Myeloma Research and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25555162
DOI: 10.1038/bcj.2014.91

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Racial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-center studyPMID 25555162Read ↗

Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentationSemantic proximity Read ↗

Variability in Cytogenetic Testing for Multiple Myeloma: A Comprehensive Analysis From Across the United StatesSemantic proximity Read ↗

Combining information regarding chromosomal aberrations t(4;14) and del(17p13) with the International Staging System classification allows stratification of myeloma patients undergoing autologous stem cell transplantationSemantic proximity Read ↗

Clinical implications of chromosomal abnormalities in multiple myelomaSemantic proximity Read ↗

Racial and ethnic differences in clonal hematopoiesis, tumor markers, and outcomes of patients with multiple myelomaSemantic proximity Read ↗

Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myelomaSemantic proximity Read ↗

Monosomy 13 Is Associated With the Transition of Monoclonal Gammopathy of Undetermined Significance to Multiple MyelomaSemantic proximity Read ↗

A pooled analysis of karyotypic patterns, breakpoints and imbalances in 783 cytogenetically abnormal multiple myelomas reveals frequently involved chromosome segments as well as significant age‐ and sex‐related differencesSemantic proximity Read ↗

Differences in genomic abnormalities among African individuals with monoclonal gammopathies using calculated ancestrySemantic proximity Read ↗

Clinical and biologic implications of recurrent genomic aberrations in myelomaSemantic proximity Read ↗

Impact of genetic abnormalities after allogeneic stem cell transplantation in multiple myeloma: a report of the Societe Francaise de Greffe de Moelle et de Therapie CellulaireSemantic proximity Read ↗

Treatment outcomes in patients with relapsed and refractory multiple myeloma and high-risk cytogenetics receiving single-agent carfilzomib in the PX-171-003-A1 studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.